Enalapril dosage in steroid-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 19, Issue 1, 2004, Pages 45-50

  Bagga, Arvind ^a   Mudigoudar, Basanagoud D ^a   Hari, Pankaj ^a   Vasudev, V ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin converting enzyme inhibitors; Hyperlipidemia; Proteinuria

Indexed keywords

ALBUMIN; ALKYLATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; HISTOPATHOLOGY; HUMAN; LOW DRUG DOSE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TITRIMETRY;

ADOLESCENT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; ENALAPRIL; FEMALE; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; PROTEINURIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0347899276     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1314-y     Document Type: Article

References (25)

1. Niaudet P (1999) Steroid-resistant idiopathic nephrotic syndrome. In: Barratt TM, Avner ED, Harmon WE (eds) Textbook on pediatric nephrology, 4th edn. Williams Wilkins, Baltimore, pp 749-763
2. Praga M, Morales E (2002) Renal damage associated with proteinuria. Kidney Int [Suppl] 82:42-46
3. Gansevoort RT, Sluiter WJ, Hemmelder MH, Zeeuw D de, Jong PE de (1995) Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963-1974
4. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, Jong PE de, Zeeuw D de, Lau J, Levey AS (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135:73-87
5. Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112:295-298
6. Fitzwater DS, Brouhard BH, Cunningham RJ 3rd (1990) Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis. Am J Dis Child 144:522
7. Milliner DS, Morgenstern BZ (1991) Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 5:587-590
8. Proesmans W, Wambeke IV, Dyck MV (1996) Long-term therapy with enalapril in patients with nephrotic-range proteinuria. Pediatr Nephrol 10:587-589
9. Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA (2000) Enalapril and prednisone in children with nephrotic-range proteinuria. Pediatr Nephrol 14:1088-1091
10. Lama G, Luongo I, Piscitelli A, Salsano ME (2000) Enalapril: antiproteinuric effect in children with nephrotic syndrome. Clin Nephrol 53:432-436
11. Heeg JE, Jong PE de, Hem GK van der, Zeeuw D de (1989) Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279
12. Indian Pediatric Nephrology Group (2001) Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr 38:975-986
13. National Heart, Lung and Blood Institute (1987) Report of the Second Task Force on Blood Pressure Control in Children. Pediatrics 79:1-25
14. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
15. Stata Corporation ( 1993) Stata Reference Manual, Release 3.1, 6 edn. College Station, Texas
16. Pocock SJ (ed) (1986) Clinical trials: a practical approach. Wiley, New York, pp 110-122
17. Bedogna V, Valvo E, Casagrande P, Braggio P, Fontanarosa C, Dal Santo F, Alberti D, Maschio G (1990) Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int 38:101-107
18. Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G (2000) ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Am J Kidney Dis 35:381-391
19. Gansevoort RT, Zeeuw D de, Jong PE de (1993) Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 44:579-584
20. Palla R, Panichi V, Finato V, Parrini M, Andreini B, Bianchi AM, Giovannini L, Migliori M, Bertelli AA (1994) Effect of increasing doses of lisinopril on proteinuria of normotensive patients with IgA nephropathy and normal renal function. Int J Clin Pharmacol Res 14:35-43
21. Ruggenenti P, Mise N, Pisoni R, Arnoldi F, Pezzotta A, Perna A, Cattaneo D, Remuzzi G (2003) Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Circulation 107:586-592
22. Haas M, Leko-Mohr Z, Erler C, Mayer G (2002) Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy. Am J Kidney Dis 40:458-463
23. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G (1998) Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53:1209-1216
24. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123:754-762
25. Mulec H, Johnsen SA, Wiklund O, Bjorck S (1993) Cholesterol: a renal risk factor in diabetic nephropathy? Am J Kidney Dis 22:196-201